Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe COVID-19”

Showing 20 of 0 results

Not applicableWithdrawnNCT04651387
What this trial is testing

Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients

Who this might be right for
SARS-CoV Infection
Neuromed IRCCS
Large-scale testing (Phase 3)Temporarily pausedNCT04341870
What this trial is testing

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Who this might be right for
COVID19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 27
Large-scale testing (Phase 3)Study completedNCT04374032
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Infection
Bosnalijek D.D 120
Large-scale testing (Phase 3)UnknownNCT04873414
What this trial is testing

Convalescent Plasma as Adjunct Therapy for COVID-19

Who this might be right for
COVID-19
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia 364
Testing effectiveness (Phase 2)Study completedNCT04363736
What this trial is testing

Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 97
Large-scale testing (Phase 3)Study completedNCT04732949
What this trial is testing

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19
Synairgen Research Ltd. 623
Early research (Phase 1)WithdrawnNCT04490486
What this trial is testing

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeCorona Virus Infection
Joshua M Hare
Testing effectiveness (Phase 2)Looking for participantsNCT05787327
What this trial is testing

RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19

Who this might be right for
COVID-19
Chinese University of Hong Kong 96
Testing effectiveness (Phase 2)UnknownNCT04869579
What this trial is testing

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.

Who this might be right for
Covid19
CHRISTUS Health 100
Large-scale testing (Phase 3)Study completedNCT05999435
What this trial is testing

Study of LAU-7b for the Treatment of Long COVID in Adults

Who this might be right for
Long COVID
Laurent Pharmaceuticals Inc. 272
Not applicableStudy completedNCT04657445
What this trial is testing

EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY

Who this might be right for
Olfactory and Taste Dysfunction in SARS-CoV2 Infection
University Hospital, Ioannina 100
Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Not applicableWithdrawnNCT04953312
What this trial is testing

Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)

Who this might be right for
Severe/Moderate CoronavirusChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)WithdrawnNCT04355676
What this trial is testing

Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19

Who this might be right for
Coronavirus Infection
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)Ended earlyNCT04458948
What this trial is testing

Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients

Who this might be right for
COVID-19
University of New Mexico 28
Early research (Phase 1)UnknownNCT05083000
What this trial is testing

Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care

Who this might be right for
COVID-19 Respiratory Infection
National University Hospital, Singapore 24
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Large-scale testing (Phase 3)Ended earlyNCT04928430
What this trial is testing

Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Who this might be right for
COVID-19
Xenothera SAS 290
Testing effectiveness (Phase 2)Ended earlyNCT04679350
What this trial is testing

Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19
ImmuneMed, Inc. 1
Not applicableStudy completedNCT04389944
What this trial is testing

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Who this might be right for
Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)
University Hospital, Basel, Switzerland 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation